Offerings

Delayed 55s

Equity and debt offerings as they're announced.

Signed out · Sign up for real-time

Updates arrive automatically.

  • Elite Express Holding Inc. Announces Plans to Pursue Strategic Acquisitions and Identify Potential Acquisition Targets
    PR·

    Elite Express Holding Inc. Announces Plans to Pursue Strategic Acquisitions and Identify Potential Acquisition Targets

    Elite Express Holding Inc. ("ETS" or the "Company") (Nasdaq CM: ETS), a California-based provider of last-mile delivery services, today announced that it is seeking potential acquisition targets as part of its strategy to expand its business through strategic acquisitions. The Company currently anticipates pursuing one or more acquisitions with an aggregate transaction value of approximately $20 million to $30 million. The Company is exploring potential acquisition targets that it believes may complement or expand its existing business, enhance its scale and service capabilities, and diversify its revenue streams. The acquisition ini

  • Iambic Presents Preclinical Data for CDK2/4 Inhibitor IAM-C1 and Brain-Penetrant KIF18A Inhibitor IAM217 at 2026 EORTC-NCI-AACR Symposium
    PR·

    Iambic Presents Preclinical Data for CDK2/4 Inhibitor IAM-C1 and Brain-Penetrant KIF18A Inhibitor IAM217 at 2026 EORTC-NCI-AACR Symposium

    IAM-C1, a selective dual CDK2/4 inhibitor, showed single-agent antitumor activity across CDK2-, CDK4- and CDK2/CDK4-dependent models, including a CDK4/6 inhibitor-resistant breast cancer patient-derived xenograft modelIAM-C1 produced smaller neutrophil reductions than combined selective CDK2 and CDK4 inhibition, despite higher exposure multiplesIAM217, a brain-penetrant KIF18A inhibitor, drove deep regressions across multiple preclinical models with approximately 90% regression in an intracranial breast cancer modelBoth wholly owned drug candidates were designed using Iambic’s AI-driven, molecular superintelligence platform and are advancing toward the clinic, with a Safe-to-Proceed Letter r

  • Modern Mining Plans Its First Commercial-Scale E-Waste Gold Plant, With Capacity for About 40,000 Gold Equivalent Ounces a Year; Files Third Quarter 2026 Financial Statements
    PR·

    Modern Mining Plans Its First Commercial-Scale E-Waste Gold Plant, With Capacity for About 40,000 Gold Equivalent Ounces a Year; Files Third Quarter 2026 Financial Statements

    US$40 million IPO supports 18-month build-out in North Carolina, building on 41 settled product lots at Greenville demonstration facilityModern Mining Technology Corp. (NYSE:MDRN) ("Modern Mining" or the "Company"), which recovers gold, silver, copper and other valuable metals from electronic waste using a proprietary aqueous-based process, announced today it has laid out an 18-month plan to build its first commercial-scale operation in North Carolina, designed with an annual capacity to produce approximately 40,000 gold equivalent ounces. The plan follows the Nov. 12, 2026, closing of the Company’s approximately US$40 million initial public offering ("IPO"). Modern Mining has proven it can r

  • Yesway Announces Launch of Secondary Public Offering
    PR·

    Yesway Announces Launch of Secondary Public Offering

    Yesway, Inc. (NASDAQ:YSWY) ("Yesway") today announced that certain of its existing stockholders intend to offer for sale in an underwritten secondary offering 5,000,000 shares of Yesway’s Class A common stock. In addition, the underwriters of the offering will have a 30-day option to purchase from the selling stockholders up to 750,000 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The selling stockholders will receive all of the net proceeds from this offering. Morgan Stanley is acting as lead bookrunning manager for the offering. The offering will be made only by m

  • KBR Announces Launch of Trinzic’s Senior Notes Offering
    PR·

    KBR Announces Launch of Trinzic’s Senior Notes Offering

    KBR (NYSE:KBR) announced today that Solar MTS Holdings LLC, a wholly owned subsidiary of KBR, has commenced a private offering of $500 million in aggregate principal amount of senior notes due 2035 (the "Notes"). The precise size, timing and terms of the Notes offering are subject to market conditions and other factors. The Notes are being offered in connection with the planned spin-off of KBR’s Mission Technology Solutions business ("MTS") into an independent, publicly traded company, Trinzic, Inc. ("Trinzic"). The spin-off is anticipated to be completed on January 4, 2027, subject to final approval by KBR’s board of directors and other customar

  • McGraw Hill, Inc. to Outline Vision for Education, Long-Term Strategy and Multi-Year Financial Framework at Its Investor Day on November 18, 2026
    PR·

    McGraw Hill, Inc. to Outline Vision for Education, Long-Term Strategy and Multi-Year Financial Framework at Its Investor Day on November 18, 2026

    McGraw Hill, Inc. (the "Company") is a leading education franchise with trusted, institutional relationships across Higher Education, K-12 and professional learning and provides a foundation for growth and long-term value creation. The Company to outline its agentic AI strategy to deepen monetization of its 100+ million active curriculum licenses. Company leadership team to introduce a multi-year financial framework focused on profitable growth, free cash flow generation, leverage target attainment and disciplined capital allocation. McGraw Hill, Inc. (NYSE:MH), a leading global provider of education solutions for preK-12, higher education and professional learning, supporting the

  • Medline Inc. announces pricing of secondary offering of Class A common stock
    PR·

    Medline Inc. announces pricing of secondary offering of Class A common stock

    Medline Inc. (NASDAQ:MDLN) ("Medline") announced today the pricing of its secondary offering of 60,000,000 shares of Medline’s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC along with GIC Private Limited and its managed affiliate and a wholly owned subsidiary of the Abu Dhabi Investment Authority (collectively, the "Selling Stockholders") at a price to the public of $35.50 per share (the "Offering"). The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline’s Class A common st

  • Autozi Internet Technology (Global) Ltd. Announces Closing of $12.75 Million Senior Secured Convertible Notes Offering
    PR·

    Autozi Internet Technology (Global) Ltd. Announces Closing of $12.75 Million Senior Secured Convertible Notes Offering

    Autozi Internet Technology (Global) Ltd. ("Autozi" or the "Company") (NASDAQ:AZI), one of the leading and fast-growing lifecycle automotive service providers in China, today announced that, on November 17, 2026, it entered into a definitive Securities Purchase Agreement (the "Agreement") with the investors identified in the schedule of buyers thereto (collectively, the "Investors") and completed the initial closing of the transactions contemplated by the Agreement (the "Initial Closing"), at which the Company issued and sold senior secured convertible notes in an aggregate original principal amount of $12.75 million (the "Initial Notes") in a regi

  • Ardent Health Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
    PR·

    Ardent Health Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase

    Ardent Health, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company") today announced the pricing of the previously announced secondary public offering (the "Offering") of 8,000,000 shares of its common stock, consisting of 7,136,719 shares of its common stock by an affiliate of Equity Group Investments and 863,281 shares of its common stock by an affiliate of Ventas, Inc. (together, the "Selling Stockholders") at a price to the public of $14.50 per share. In connection with the Offering, the Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price, less the underwriting discounts and commissions.

  • PT Freeport Indonesia Prices U.S.$750.0 Million of Senior Notes
    PR·

    PT Freeport Indonesia Prices U.S.$750.0 Million of Senior Notes

    PT Freeport Indonesia ("PTFI" or the "Company") announced today that it has agreed to sell (the "Notes Offering") U.S.$750.0 million of 6.90% senior notes due 2033 (the "Notes") priced at par of their principal amount. The Notes are expected to be rated "Baa3" by Moody’s and "BBB" by Fitch. The sale of the Notes is expected to settle on November 24, 2026, subject to customary closing conditions. PTFI intends to use the net proceeds from the Notes Offering to refinance existing indebtedness and for general corporate purposes. Interest on the Notes will be payable semi-annually in arrears on May 24 and November 24 of each year, beginning on May 24, 2027. The Notes will mature on Novembe

  • reAlpha (Nasdaq: AIRE) Reports Third-Quarter 2026 Financial Results
    PR·

    reAlpha (Nasdaq: AIRE) Reports Third-Quarter 2026 Financial Results

    reAlpha Tech Corp. (NASDAQ:AIRE) (the "Company" or "reAlpha"), an AI-powered real estate technology company, today announced financial results and business highlights for the third quarter ended September 30, 2026. Financial Highlights (All figures are approximate and compared to the third quarter of 2025 unless otherwise stated.) Revenue totaled approximately $1.6 million in the third quarter of 2026, compared to approximately $1.4 million in the third quarter of 2025, an increase of approximately 11%. Homebuying Services Segment revenue was approximately $1.3 million, compared to approximately $1.0 million in the prior-year period, an in

  • CORRECTING and REPLACING Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase
    PR·

    CORRECTING and REPLACING Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase

    Please replace the release with the following corrected version due to multiple revisions. The updated release reads: ARDENT HEALTH ANNOUNCES PROPOSED SECONDARY OFFERING OF COMMON STOCK AND CONCURRENT SHARE REPURCHASE Ardent Health, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company") today announced the commencement of a proposed secondary public offering (the "Offering") of 8,000,000 shares of its common stock, consisting of 7,136,719 shares of its common stock by an affiliate of Equity Group Investments and 863,281 shares of its common stock by an affiliate of Ventas, Inc. (together, the "Selling Stockholders"). In connection with the Offering, the Selling Stockholders intend to gra

  • Restaurant Brands International Inc. Announces Pricing of Senior Secured Notes Offering
    PR·

    Restaurant Brands International Inc. Announces Pricing of Senior Secured Notes Offering

    Restaurant Brands International Inc. ("RBI") (NYSE:QSR) (TSX:QSR) (TSX:QSP), 1011778 B.C. Unlimited Liability Company (the "Issuer") and New Red Finance, Inc. (together with the Issuer, the "Issuers") announced today that the Issuers have priced a public offering (the "Offering") of $500 million aggregate principal amount of 6.00% Senior Secured Notes due 2031 (the "2031 Notes") and $500 million aggregate principal amount of 6.40% Senior Secured Notes due 2036 (together with the 2031 Notes, the "Notes"). The closing of the Offering is expected to occur on or about November 24, 2026, subject to customary closing conditions.

  • Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase
    PR·

    Ardent Health Announces Proposed Secondary Offering of Common Stock and Concurrent Share Repurchase

    Ardent Health, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company") today announced the commencement of a proposed secondary public offering (the "Offering") of 6,244,629 shares of its common stock by an affiliate of Equity Group Investments and 755,371 shares of its common stock by an affiliate of Ventas, Inc. (together, the "Selling Stockholders"). In connection with the Offering, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. Subject to the completion of the Offering, the Company intends to concurrently repurchase from

  • SELLAS Life Sciences Announces Proposed $150.0 Million Underwritten Public Offering
    PR·

    SELLAS Life Sciences Announces Proposed $150.0 Million Underwritten Public Offering

    SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it has commenced an underwritten public offering of $150.0 million of shares of its common stock. SELLAS intends to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock under the same terms and conditions. All of the shares in the offering will be sold by SELLAS. The offering is subject to market and other conditions, and there can be no assurance as to wheth

  • Millicom (Tigo) announces proposed Offering of Senior Notes due 2033
    PR·

    Millicom (Tigo) announces proposed Offering of Senior Notes due 2033

    Millicom (Tigo) announces proposed Offering of Senior Notes due 2033 Luxembourg, November 17, 2026 – Millicom International Cellular S.A. ("Millicom") today announced that it is commencing a private offering of Senior Notes due 2033 (the "Notes") that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). Millicom expects to use the proceeds from the issuance of the Notes, together with cash on hand, to (i) fund the purchase of any and all of Millicom’s outstanding 6.250% senior notes due 2029 (the "6.250% Notes") validly tendered and accepted for purchase in a concurrent tender offer (the "Tender Offer"), (ii) redeem any 6.250% Notes

  • Controlled Thermal Resources Appoints BBVA to Lead $420 Million Stage 1 Power Project Debt Financing
    PR·

    Controlled Thermal Resources Appoints BBVA to Lead $420 Million Stage 1 Power Project Debt Financing

    Controlled Thermal Resources Holdings Inc. ("CTR" or the "Company") today announced that it has appointed BBVA, a leading global financial group, as financial advisor to assist in structuring, arranging and syndicating the approximately $420 million debt financing for Stage 1 Power at its Hell’s Kitchen project in Imperial County, California. Stage 1 Power is a planned 50 MW baseload geothermal power facility on the northern extension of the Salton Sea Known Geothermal Resource Area, a field that has generated electricity since 1982. It is the first phase of the Hell’s Kitchen power build-out, targeted for commercial operation in the fir

  • Insight Molecular Diagnostics Announces Pricing of $15 Million Public Offering
    PR·

    Insight Molecular Diagnostics Announces Pricing of $15 Million Public Offering

    Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) ("iMDx," "we," "us," "our," or the "Company") today announced the pricing of its underwritten public offering of 8,296,429 shares of its common stock at a price to the public of $1.75 per share and pre-funded warrants to purchase up to 275,000 shares of common stock at a price to the public of $1.7499 per pre-funded warrant, which represents the per share public offering price of each share of common stock, less the $0.0001 per share exercise price for each pre-funded warrant. All of the shares and pre-funded warrants in the offering are being sold by iMDx. In addition, the Company has gran

  • BP p.l.c. Launches Cash Tender Offers for USD Notes for Aggregate Purchase Consideration of Up to $6 Billion
    PR·

    BP p.l.c. Launches Cash Tender Offers for USD Notes for Aggregate Purchase Consideration of Up to $6 Billion

    BP p.l.c. ("BP") (NYSE:BP) (LSE: BP) today announced the commencement by its wholly-owned subsidiaries BP Capital Markets America Inc. ("BPCMA") and BP Capital Markets p.l.c. ("BPCM" and, together with BPCMA, the "Offerors" and each an "Offeror") of sixteen concurrent and separate offers (each, a "Tender Offer" and collectively, the "Tender Offers") to purchase for cash any and all of the outstanding notes of the series listed in the table below (collectively, the "Notes"), subject to the Maximum Purchase Condition (as defined below). The Tender Offers are being made upon the terms and subject to the conditions set forth in the offer to purchase da

  • ITT Appoints Blaine Browers as Chief Financial Officer
    PR·

    ITT Appoints Blaine Browers as Chief Financial Officer

    November 17, 2026-- ITT Inc. (NYSE: ITT), a leading manufacturer of highly engineered critical components and customized technology solutions, today announced the appointment of Blaine Browers as Senior Vice President and Chief Financial Officer, effective January 1, 2027. Browers will report to Chief Executive Officer and President Luca Savi. He succeeds Interim CFO Michael Savinelli who will continue as Vice President, Finance, Chief Tax Officer, Treasurer and Assistant Secretary. Browers is a seasoned executive with more than two decades of experience leading financial organizations within global industrial businesses. He has a strong track record of improving profitability and strengt